REG-Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
Globe Newswire•28/09/2026•11:00 ET
0
Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
Copenhagen, Denmark, September 28, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the “Program”) for week 39 (September 21 - September 25, 2026).
Get started
Create a free account to read the full story and Whiz Insights.